You have 9 free searches left this month | for more free features.

Hepatitis C Genotype 5 (GT 5)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Trial (ABT-493/ABT-530)

Completed
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

Completed
  • HCV
  • +2 more
  • (no location specified)
Jul 28, 2021

Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

Completed
  • Hepatitis C Virus Infection
  • +2 more
  • (no location specified)
Jul 9, 2021

Alcoholic Hepatitis, Sepsis Trial in Richmond (Vitamin C, Dextrose 5% in water)

Completed
  • Alcoholic Hepatitis
  • Sepsis
  • Vitamin C
  • Dextrose 5% in water
  • Richmond, Virginia
    Virginia Commonwealth University
Aug 1, 2022

Hepatitis C Virus Infection Trial (OBV/PTV/r) ± ribavirin (RBV))

Completed
  • Hepatitis C Virus Infection
  • OBV/PTV/r) ± ribavirin (RBV)
  • (no location specified)
May 9, 2020

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

Completed
  • Hepatitis C Virus (HCV)
  • San Diego, California
  • +24 more
Jul 14, 2021

Hepatitis C Trial (Grazoprevir, Elbasvir, Ribavirin)

Completed
  • Hepatitis C
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

Completed
  • Chronic Hepatitis C
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

Completed
  • Hepatitis C Infection
  • (no location specified)
Jan 15, 2021

Immune Response in Patients With Hepatitis B and C Infection

Recruiting
  • Hepatitis B
  • Hepatitis C
    • Basildon, Essex, United Kingdom
      Basildon Hospital
    Apr 5, 2022

    Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)

    Active, not recruiting
    • Hepatitis B, Chronic
    • Tenofovir disoproxil fumarate
    • Toronto, Ontario, Canada
      University Health Network - Toronto General Hospital
    Nov 1, 2022

    Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)

    Completed
    • Hepatitis C, Chronic
    • Elbasvir, Grazoprevir 50-100Mg Oral Tablet
    • Riyadh, Saudi Arabia
      King Fahad Medical City
    Nov 18, 2020

    Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual

    Recruiting
    • Hepatitis C Virus Infection, Response to Therapy of
    • Test and treat plus peer mentors
    • Usual care
    • Birmingham, Alabama
    • +3 more
    Dec 9, 2022

    Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))

    Active, not recruiting
    • Hepatitis B
    • Baltimore, Maryland
    • +9 more
    Jan 17, 2023

    Hepatitis B Trial in Worldwide (GSK3228836, Nucleos(t)ide therapy)

    Recruiting
    • Hepatitis B
    • Boston, Massachusetts
    • +3 more
    Aug 24, 2022

    Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir (SOF), Ledipasvir/Sofosbuvir (LDV/SOF), Sofosbuvir/Velpatasvir

    Terminated
    • Hepatitis C Virus Infection
    • Sofosbuvir (SOF)
    • +3 more
    • Phoenix, Arizona
    • +50 more
    Jan 25, 2023

    Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

    Recruiting
    • Hepatitis B, Chronic
    • Vancouver, British Columbia, Canada
    • +31 more
    Jan 17, 2023

    Hepatitis C Trial (Grazoprevir, Uprifosbuvir, Elbasvir)

    Completed
    • Hepatitis C
    • (no location specified)
    Jul 18, 2019

    Aortic Valve Disease, Aortic Valve Disorder Trial in Worldwide (Trifecta GT (Glide Technology) Valve)

    Active, not recruiting
    • Aortic Valve Disease
    • Aortic Valve Disorder
    • Trifecta GT (Glide Technology) Valve
    • Rochester, Minnesota
    • +26 more
    Mar 10, 2022

    Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

    Completed
    • Hepatitis C
    • HCV
    • San Antonio, Texas
      Texas Liver Institute
    Jan 15, 2021

    Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

    Recruiting
    • Chronic Hepatitis C Infection
    • PR4 + LDV/SOF + ASV 4 wk
    • +7 more
    • Beijing, Beijing, China
    • +1 more
    Aug 27, 2021

    Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

    Terminated
    • Hepatitis B, Chronic
    • Hillsborough, New Jersey
    • +11 more
    Dec 28, 2022

    Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

    Completed
    • Hepatitis C Virus (HCV)
    • Glecaprevir/pibrentasvir adult formulation
    • Glecaprevir/pibrentasvir pediatric formulation
    • San Francisco, California
    • +37 more
    Sep 19, 2022

    Hepatitis B, Chronic Trial in Worldwide (VIR-2218, VIR-3434, PEG-IFNa)

    Recruiting
    • Hepatitis B, Chronic
    • San Francisco, California
    • +39 more
    Oct 3, 2022